| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $86K | +616.7% |
| R&D Expense | $10.7M | -16.6% |
| SG&A Expense | $13.1M | -23.6% |
| Operating Income | -$23.8M | +20.8% |
| Pre-tax Income | -$46.9M | -154.4% |
| Income Tax | $30K | +0.0% |
| Net Income | -$46.9M | -154.0% |
| EPS (Basic) | -$1.35 | -17.4% |
| EPS (Diluted) | -$1.35 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.0M | +156.7% |
| Current Assets | $20.0M | +23.2% |
| Total Assets | $20.4M | +19.9% |
| Current Liabilities | $7.0M | +24.3% |
| Total Liabilities | $7.1M | +21.1% |
| Stockholders' Equity | $13.4M | +19.4% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | +21.0% |
| Capital Expenditures | $8K | -97.1% |
| Investing Cash Flow | -$8K | +97.1% |
| Financing Cash Flow | $21.4M | — |
| Free Cash Flow | -$12.5M | +22.3% |
| -17.4% |